• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AGA MEDICAL CORPORATION AMPLATZER SEPTAL OCCLUDER; CARDIAC OCCLUSION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AGA MEDICAL CORPORATION AMPLATZER SEPTAL OCCLUDER; CARDIAC OCCLUSION DEVICE Back to Search Results
Model Number 9-ASD-013
Device Problems Inadequacy of Device Shape and/or Size (1583); Unintended Movement (3026)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 10/27/2016
Event Type  Injury  
Manufacturer Narrative
(b)(4).The results of the investigation are inconclusive since the device was not returned for analysis.Our investigation was limited to the review of the device history record, which showed that each manufacturing and inspection operation was performed and indicated complete in accordance with sjm specifications and procedures.Based on the information received, the cause of the reported incident could not be conclusively determined.
 
Event Description
A 16 mm amplatzer septal occluder (aso) was deployed using an 8f amplatzer torqvue 45 delivery system (dtv45) however; as the disc edge pressed the posterior wall of the aorta the device was removed.A 14 mm aso was then attempted to be deployed and per report once again, the disc edge pressed the posterior wall of the aorta, so it was removed.Next, a 13 mm aso was successfully implanted and the position was confirmed prior to release of the aso from the delivery cable.After release, the aso once again, appeared too close to the posterior wall of the aorta and the device was attempted to be removed percutaneously using a 9f dtv45 and a 10 mm gooseneck snare.During snaring, the aso became hung up at the distal tip of the 9f dtv45 sheath and was unable to be pulled into the delivery sheath.The 9f dtv45 and the gooseneck snare were removed from the patient without consequences and the 9f dtv45 was replaced with a 10f dtv45.The same gooseneck snare was delivered through the 10f dtv45 delivery sheath and after several attempts to retrieve the aso, the device embolized to the left ventricle.Surgical intervention was required for the retrieval of the aso and the defect was closed with a pericardial patch.The patient is reported to be in stable condition.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER SEPTAL OCCLUDER
Type of Device
CARDIAC OCCLUSION DEVICE
Manufacturer (Section D)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer Contact
denise johnson
5050 nathan lane north
plymouth, MN 55442
6517564470
MDR Report Key6072478
MDR Text Key58988605
Report Number2135147-2016-00105
Device Sequence Number1
Product Code MLV
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P000039
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 10/27/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/31/2019
Device Model Number9-ASD-013
Device Catalogue Number9-ASD-013
Device Lot Number4949838
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/27/2016
Initial Date FDA Received11/02/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/22/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age19 YR
Patient Weight27
-
-